MSB mesoblast limited
Add to My Watchlist 3.91% ! $2.21

I heard neurological diseases mentioned , along with lupus and...

  1. Kohbee
    216 Posts.
    lightbulb Created with Sketch. 26
    clock Created with Sketch.
    09/04/26
    01:45
    Post #: 83520110
    I heard neurological diseases mentioned , along with lupus and possibly cancer ?
    nothing about asthma ?? Yet ? Maybe when they start bringing in the billions they speak of perhaps ;-)
    MSB Price at posting: $2.04 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Fire fallout: Viva Energy insists it can return Geelong refinery to nearly full production within weeks
right-arrow Created with Sketch.
NEWS Leeuwin lands huge regulatory milestone that leaves Marda with 100% of resources across granted leases
right-arrow Created with Sketch.
NEWS Money and Investing: Four income streams every investor needs - Earned, business, investment, and passive, explained
right-arrow Created with Sketch.
NEWS Is Australia's interest rate playbook finally starting to break?
right-arrow Created with Sketch.
NEWS Lindian secures fuel, cost certainty for Kangankunde rare earth development
right-arrow Created with Sketch.
NEWS the daily moo: what you need to know every morning
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$2.21 		Change
-0.090(3.91%) 		Mkt cap ! $2.971B
Open High Low Volume
$2.26 $2.28 $2.18 2.787M

Buyers (Bids)

Vol. Price($)
36096 $2.20
 

Sellers (Offers)

Price($) Vol.
$2.23 48799
Last trade - 16.25pm 22/04/2026 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.